Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Savettieri

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Neurology|July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosisG Tedeschi, L Lavorgna, P Russo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2009
The pharmacovigilance program on natalizumab in Italy: 2 years of experienceG Tedeschi, M P Amato, R D'Alessandro, et al.
Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Neurology|July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosisG Tedeschi, L Lavorgna, P Russo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2009
The pharmacovigilance program on natalizumab in Italy: 2 years of experienceG Tedeschi, M P Amato, R D'Alessandro, et al.
Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 12